11.87

3.76% 0.415

Anika Therapeutics Inc (ANIK)

Overview News Price History Option Chain Financials Discussions Forecast

Anika Therapeutics Inc stock is traded at $11.87, with a volume of 24,961. It is up +3.76% in the last 24 hours and down -20.00% over the past month. Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.

Previous Close:

$11.45

Open:

$11.45

24h Volume:

24,961

Relative Volume:

0.34

Market Cap:

$170.60M

Revenue:

$166.88M

Net Income/Loss:

$-74.18M

P/E Ratio:

-2.3402

EPS:

-5.07

Net Cash Flow:

$1.14M

1W Performance:

+6.64%

1M Performance:

-20.00%

6M Performance:

-31.53%

1Y Performance:

-55.47%

1-Day Range:

$11.38

$11.90

1-Week Range:

$10.89

$11.88

52-Week Range:

$10.89

$29.11

Anika Therapeutics Inc Stock (ANIK) Company Profile

Name

Anika Therapeutics Inc

Sector

Healthcare (1170)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

(781) 457-9000

Address

32 WIGGINS AVENUE, BEDFORD, MA

Employee

288

Twitter

Next Earnings Date

2025-03-12

Latest SEC Filings

ANIK's Discussions on Twitter

Compare ANIK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ANIK Anika Therapeutics Inc	11.90	159.76M	166.88M	-74.18M	1.14M	-5.07
HLN Haleon Plc Adr	11.08	50.54B	14.35B	1.85B	0	0.4023
ZTS Zoetis Inc	170.93	74.02B	9.29B	2.52B	2.28B	5.57
RDHL Redhill Biopharma Ltd Adr	1.8576	4.22M	35.75M	11.57M	-26.25M	-3.8069
TAK Takeda Pharmaceutical Co Adr	14.95	45.82B	30.08B	710.16M	4.45B	0.2182
TEVA Teva Pharmaceutical Industries Ltd Adr	17.32	20.31B	16.54B	-1.64B	749.00M	-1.45

Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-17-25	Initiated	B. Riley Securities	Buy
Nov-01-24	Reiterated	Barrington Research	Outperform
Aug-14-23	Upgrade	Barrington Research	Mkt Perform → Outperform
Mar-07-23	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-09-22	Upgrade	Barrington Research	Mkt Perform → Outperform
Oct-14-22	Resumed	Stephens	Equal-Weight
Mar-09-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-09-22	Downgrade	Stephens	Overweight → Equal-Weight
Nov-16-21	Initiated	Stephens	Overweight
Jul-16-21	Initiated	UBS	Neutral
Dec-16-20	Upgrade	Barrington Research	Mkt Perform → Outperform
May-08-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Jan-21-20	Upgrade	Sidoti	Neutral → Buy
Jan-10-20	Upgrade	First Analysis Sec	Outperform → Strong Buy
Nov-05-19	Initiated	BWS Financial	Sell
Sep-24-19	Reiterated	Barrington Research	Outperform
Sep-23-19	Downgrade	First Analysis Sec	Strong Buy → Outperform
Jul-25-19	Upgrade	First Analysis Sec	Neutral → Strong Buy
Feb-22-19	Downgrade	First Analysis Sec	Outperform → Neutral
Feb-22-19	Downgrade	Sidoti	Buy → Neutral
Jul-27-18	Upgrade	Barrington Research	Mkt Perform → Outperform
Jun-20-18	Downgrade	Barrington Research	Outperform → Mkt Perform
Jun-20-18	Downgrade	First Analysis Sec	Overweight → Equal-Weight
May-04-18	Upgrade	Barrington Research	Mkt Perform → Outperform
Feb-23-18	Downgrade	Barrington Research	Outperform → Mkt Perform
Jan-24-18	Upgrade	First Analysis Sec	Equal-Weight → Overweight
Oct-27-17	Reiterated	Barrington Research	Outperform
May-09-16	Upgrade	Singular Research	BUY - Long-Term → Buy
Apr-27-16	Downgrade	Northland Capital	Outperform → Market Perform
Feb-26-16	Reiterated	Barrington Research	Outperform

View All

Anika Therapeutics Inc Stock (ANIK) Latest News

03:17 AM

Ameriprise Financial Inc. Boosts Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

03:17 AM

May 31, 2025

Long Term Trading Analysis for (ANIK) - news.stocktradersdaily.com

May 31, 2025

Jane Street Group LLC Acquires 3,065 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

May 31, 2025

May 29, 2025

BNP Paribas Financial Markets Increases Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

May 29, 2025

May 26, 2025

Deutsche Bank AG Lowers Stock Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

May 26, 2025

May 15, 2025

Orthopedic Regenerative Medicine Market Is Booming Worldwide | - openPR.com

May 15, 2025

May 14, 2025

Anika Therapeutics focuses on Hyalofast and Cingal advancements for 2025 growth - MSN

May 14, 2025

May 13, 2025

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ANIK Stock News - GuruFocus

May 13, 2025

Anika Therapeutics (ANIK) Sees Target Price Adjustment Amid Futu - GuruFocus

May 13, 2025

Tower Research Capital LLC TRC Acquires 2,326 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

May 13, 2025

Anika Therapeutics (NASDAQ:ANIK) Downgraded by StockNews.com to “Hold” - Defense World

May 13, 2025

May 12, 2025

Anika Therapeutics (ANIK) Stock Maintains "Outperform" Rating De - GuruFocus

May 12, 2025

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 12, 2025

Viscosupplementation Market: Executive Briefing & Strategic - openPR.com

May 12, 2025

May 11, 2025

Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates - MSN

May 11, 2025

Wells Fargo & Company MN Boosts Stock Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

May 11, 2025

May 10, 2025

Investor Network: Anika Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire

May 10, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025

Anika Therapeutics First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

May 10, 2025

Revenues Working Against Anika Therapeutics, Inc.'s (NASDAQ:ANIK) Share Price - simplywall.st

May 10, 2025

Anika Therapeutics (ANIK) Faces OEM Challenges Amid Commercial G - GuruFocus

May 10, 2025

Dimensional Fund Advisors LP Sells 50,011 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

May 10, 2025

Anika: Q1 Earnings Snapshot - News-Times

May 10, 2025

Anika Reports First Quarter 2025 Financial Results - GlobeNewswire

May 10, 2025